130 related articles for article (PubMed ID: 1622733)
1. Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer.
Nio Y; Tsubono M; Tseng CC; Morimoto H; Kawabata K; Masai Y; Shiraishi T; Imai S; Ohgaki K; Tobe T
Biotherapy; 1992; 4(2):117-28. PubMed ID: 1622733
[TBL] [Abstract][Full Text] [Related]
2. In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer.
Sugimachi K; Maehara Y; Kusumoto T; Okamura T; Korenaga D; Kohnoe S; Baba H; Anai H
Anticancer Res; 1995; 15(5B):2175-9. PubMed ID: 8572620
[TBL] [Abstract][Full Text] [Related]
3. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
Mizutani Y; Yoshida O
J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
[TBL] [Abstract][Full Text] [Related]
4. In vitro immunomodulating effect of protein-bound polysaccharide, PSK on peripheral blood, regional nodes, and spleen lymphocytes in patients with gastric cancer.
Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Imai S; Tobe T
Cancer Immunol Immunother; 1991; 32(6):335-41. PubMed ID: 1901030
[TBL] [Abstract][Full Text] [Related]
5. Effect of PSK and its subfractions on peripheral blood lymphocytes mediated cytotoxicity against urinary bladder tumor cells.
Mizutani Y; Nio Y; Yoshida O
J Urol; 1992 Nov; 148(5):1571-6. PubMed ID: 1433570
[TBL] [Abstract][Full Text] [Related]
6. Polysaccharide preparation PSK augments the proliferation and cytotoxicity of tumor-infiltrating lymphocytes in vitro.
Noguchi K; Tanimura H; Yamaue H; Tsunoda T; Iwahashi M; Tani M; Mizobata S; Hotta T; Arii K; Tamai M
Anticancer Res; 1995; 15(2):255-8. PubMed ID: 7762991
[TBL] [Abstract][Full Text] [Related]
7. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer--7-year survival--Cooperative Study Group for Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].
Ichihashi H; Kondo T; Nakazato H
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2758-66. PubMed ID: 3307635
[TBL] [Abstract][Full Text] [Related]
8. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer.
Tanaka H; Muguruma K; Ohira M; Kubo N; Yamashita Y; Maeda K; Sawada T; Hirakawa K
Anticancer Res; 2012 Aug; 32(8):3427-33. PubMed ID: 22843926
[TBL] [Abstract][Full Text] [Related]
9. Alternating immunochemotherapy of advanced gastric carcinoma: a randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resection.
Kondo T; Sakamoto J; Nakazato H
Biotherapy; 1991; 3(4):287-95. PubMed ID: 1786194
[TBL] [Abstract][Full Text] [Related]
10. [Immunoregulatory effects of PSK on the Th1/Th2 balance and regulatory T-cells in patients with colorectal cancer].
Yoshino S; Yoshimura K; Suzuki N; Iida M; Yoshida S; Maeda Y; Maeda K; Hazama S; Oka M
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2234-6. PubMed ID: 21224532
[TBL] [Abstract][Full Text] [Related]
11. [The effect of PSK on laryngeal cancer].
Saito H; Hozawa J; Kamata S; Hakamada M; Kasahara M; Takagi A
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1061-7. PubMed ID: 7184440
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker.
Kudo S; Tanaka J; Kashida H; Tamegai Y; Endo S; Yamano HO
Oncol Rep; 2002; 9(3):635-8. PubMed ID: 11956642
[TBL] [Abstract][Full Text] [Related]
13. The effect and distribution of a protein-bound polysaccharide preparation, PSK (Krestin), intratumorally injected prior to surgery into gastric cancer patients.
Tomochika H; Gouchi A; Okanobu K; Sasaki A; Fuchimoto S; Orita K
Acta Med Okayama; 1989 Oct; 43(5):289-97. PubMed ID: 2610006
[TBL] [Abstract][Full Text] [Related]
14. Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide.
Kato M; Hirose K; Hakozaki M; Ohno M; Saito Y; Izutani R; Noguchi J; Hori Y; Okumoto S; Kuroda D
Cancer Immunol Immunother; 1995 Mar; 40(3):152-6. PubMed ID: 7728773
[TBL] [Abstract][Full Text] [Related]
15. Prognostic markers for immunochemotherapy using tegafur -uracil (UFT) and protein-bound polysaccharide K (PSK).
Yoshinaga K; Saeki H; Oki E; Morita M; Ikeda T; Sugimachi K; Yamashita Y; Ikegami T; Uchiyama H; Yoshizumi T; Soejima Y; Kawanaka H; Mimori K; Watanabe M; Maehara Y
Fukuoka Igaku Zasshi; 2013 Dec; 104(12):549-58. PubMed ID: 24693683
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK.
Matsunaga K; Iijima H; Aota M; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
J Clin Lab Immunol; 1992 Jan; 37(1):21-37. PubMed ID: 1339233
[TBL] [Abstract][Full Text] [Related]
17. PSK may suppress CD57(+) T cells to improve survival of advanced gastric cancer patients.
Akagi J; Baba H
Int J Clin Oncol; 2010 Apr; 15(2):145-52. PubMed ID: 20229169
[TBL] [Abstract][Full Text] [Related]
18. Activation of human natural killer cells by the protein-bound polysaccharide PSK independently of interferon and interleukin 2.
Kariya Y; Inoue N; Kihara T; Okamoto N; Sugie K; Mori T; Uchida A
Immunol Lett; 1992 Feb; 31(3):241-5. PubMed ID: 1372283
[TBL] [Abstract][Full Text] [Related]
19. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and tumor-infiltrating lymphocytes activated by PSK.
Kariya Y; Okamoto N; Fujimoto T; Inoue N; Kihara T; Sugie K; Yagita M; Kanzaki H; Mori T; Uchida A
Jpn J Cancer Res; 1991 Sep; 82(9):1044-50. PubMed ID: 1938599
[TBL] [Abstract][Full Text] [Related]
20. Immunochemotherapy benefits in gastric cancer patients stratified by programmed death-1 ligand-1.
Hsu JT; Hsu CS; Le PH; Chen TC; Chou WC; Lin CY; Yeh TS
J Surg Res; 2017 May; 211():30-38. PubMed ID: 28501128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
